GlassScriptPhysician profile
Gregory R Lamberton
NPI 1003094889
$4,851.03
in general payments reported to CMS, 2019-2025
45 companies · $1,030 in 2025
The $1,030 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,289 · 2020: $360 · 2021: $225 · 2022: $760 · 2023: $617 · 2024: $570 · 2025: $1,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,217.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $357.50 | 2019-2023 | Myrbetriq |
| Antares Pharma, INC. | $334.15 | 2019-2025 | Xyosted |
| Myriad Genetic Laboratories, INC. | $332.86 | 2020-2025 | Prolaris, Precisetumor, Myrisk |
| Sumitomo Pharma America, INC. | $310.97 | 2023-2025 | Gemtesa, Orgovyx |
| Coloplast Corp | $302.55 | 2020-2025 | Torosa |
| Intuitive Surgical, INC. | $289.66 | 2019-2025 | |
| Medtronic, INC. | $206.34 | 2022-2025 | Interstim |
| Urogen Pharma, INC. | $202.21 | 2020-2025 | Jelmyto |
| Janssen Biotech, INC. | $200.03 | 2019-2023 | Erleada |
| Boston Scientific Corporation | $181.93 | 2019-2025 | Lithovue |
| Pfizer INC. | $169.85 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $157.68 | 2022-2025 | |
| Laborie Medical Technologies Corp. | $116.07 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.65 | 2019-2022 | |
| Myovant Sciences INC. | $103.53 | 2021-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lamberton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.